Fp409 * sevelamer carbonate reduces phosphaturia but has no effect on serum c-terminal fibroblast growth factor 23 levels in stage 3b/4 ckd patients : the results of a french, multicenter, double-blind, placebo-control, randomized clinical trial
Source: Nephrology Dialysis Transplantation - Category: Urology & Nephrology Authors: Liabeuf, S., Ryckelink, J. p., El Esper, N., Urena, P., Combe, C., Dussol, B., Fouque, D., Vanhille, P., Frimat, L., Thervet, E., Prie, D., Choukroun, G. Tags: CHRONIC KIDNEY DISEASE. BONE DISEASE Source Type: research
More News: Chronic Kidney Disease | Clinical Trials | Dialysis | Kidney Transplant | Kidney Transplantation | Renvela | Transplants | Urology & Nephrology